Becky L Genberg1, Jacquie Astemborski2, David Vlahov3, Gregory D Kirk2, Shruti H Mehta2. 1. Brown University, Department of Health Services, Policy and Practice, Providence, RI, USA. 2. Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA. 3. University of California-San Francisco, School of Nursing, San Francisco, CA, USA.
Abstract
AIMS: There is limited longitudinal research examining incarceration and subsequent changes in drug use among people who inject drugs (PWID) in the United States. The objective of the current study was to characterize the frequency of incarceration and estimate the association between incarceration and subsequent injection drug use among current and former PWIDs in one US city. DESIGN: ALIVE (AIDS Linked to the Intravenous Experience) is a prospective cohort study of current and former PWIDs, with semi-annual follow-up occurring since 1988. SETTING: Baltimore, Maryland, USA. PARTICIPANTS: A total of 3245 participants with 48 738 study visits were included. Participants enrolled from 1988 to 2012 with a median of 13 follow-up visits per participant (Interquartile range = 7-25). MEASUREMENTS: Incarcerations were defined as any self-reported jail or prison stays in the previous 6 months that were ≥7 days or longer. The primary outcome was defined as any self-reported injection drug use in the previous 6 months. FINDINGS: At baseline, 29% were female, 90% African American and 33% HIV-positive. Fifty-seven per cent of participants experienced at least one incarceration episode. After adjusting for confounders, there was a positive association between incarceration and subsequent injection drug use [adjusted odds ratio (AOR) = 1.48, 95% confidence interval (CI) = 1.37-1.59]; however, stratified analysis showed that the effect was restricted to those who were not injecting at the time of incarceration (AOR = 2.11, 95% CI = 1.88-2.37). CONCLUSIONS: In the United States, incarceration of people who had previously stopped injecting drugs appears to be associated with an increased risk of subsequent injecting.
AIMS: There is limited longitudinal research examining incarceration and subsequent changes in drug use among people who inject drugs (PWID) in the United States. The objective of the current study was to characterize the frequency of incarceration and estimate the association between incarceration and subsequent injection drug use among current and former PWIDs in one US city. DESIGN: ALIVE (AIDS Linked to the Intravenous Experience) is a prospective cohort study of current and former PWIDs, with semi-annual follow-up occurring since 1988. SETTING: Baltimore, Maryland, USA. PARTICIPANTS: A total of 3245 participants with 48 738 study visits were included. Participants enrolled from 1988 to 2012 with a median of 13 follow-up visits per participant (Interquartile range = 7-25). MEASUREMENTS: Incarcerations were defined as any self-reported jail or prison stays in the previous 6 months that were ≥7 days or longer. The primary outcome was defined as any self-reported injection drug use in the previous 6 months. FINDINGS: At baseline, 29% were female, 90% African American and 33% HIV-positive. Fifty-seven per cent of participants experienced at least one incarceration episode. After adjusting for confounders, there was a positive association between incarceration and subsequent injection drug use [adjusted odds ratio (AOR) = 1.48, 95% confidence interval (CI) = 1.37-1.59]; however, stratified analysis showed that the effect was restricted to those who were not injecting at the time of incarceration (AOR = 2.11, 95% CI = 1.88-2.37). CONCLUSIONS: In the United States, incarceration of people who had previously stopped injecting drugs appears to be associated with an increased risk of subsequent injecting.
Authors: Mary Sheu; Joseph Hogan; Jenifer Allsworth; Michael Stein; David Vlahov; Ellie E Schoenbaum; Paula Schuman; Lytt Gardner; Timothy Flanigan Journal: J Womens Health (Larchmt) Date: 2002-10 Impact factor: 2.681
Authors: Robin A Pollini; Jorge Alvelais; Manuel Gallardo; Alicia Vera; Remedios Lozada; Carlos Magis-Rodriquez; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2009-04-21 Impact factor: 4.492
Authors: Elizabeth L C Merrall; Azar Kariminia; Ingrid A Binswanger; Michael S Hobbs; Michael Farrell; John Marsden; Sharon J Hutchinson; Sheila M Bird Journal: Addiction Date: 2010-06-23 Impact factor: 6.526
Authors: M-J S Milloy; Jane Buxton; Evan Wood; Kathy Li; Julio S G Montaner; Thomas Kerr Journal: BMC Public Health Date: 2009-05-27 Impact factor: 3.295
Authors: Leo Beletsky; Jess Cochrane; Anne L Sawyer; Chris Serio-Chapman; Marina Smelyanskaya; Jennifer Han; Natanya Robinowitz; Susan G Sherman Journal: Am J Public Health Date: 2015-07-16 Impact factor: 9.308
Authors: Rachel Carmen Ceasar; Alex H Kral; Kelsey Simpson; Lynn Wenger; Jesse L Goldshear; Ricky N Bluthenthal Journal: Drug Alcohol Depend Date: 2020-11-23 Impact factor: 4.492
Authors: Anjalee Sharma; Kevin E O'Grady; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Robert P Schwartz Journal: Subst Abuse Rehabil Date: 2016-04-27
Authors: Louisa Degenhardt; Amy Peacock; Samantha Colledge; Janni Leung; Jason Grebely; Peter Vickerman; Jack Stone; Evan B Cunningham; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Paul Griffiths; Richard P Mattick; Matthew Hickman; Sarah Larney Journal: Lancet Glob Health Date: 2017-10-23 Impact factor: 26.763